| AD | Alzheimer’s disease |
| ASO | Anti-sense oligonucleotide |
| BBB | Blood-brain barrier |
| CBD | Corticobasal degeneration |
| CNS | Central nervous system |
| CSF | Cerebral spinal fluid |
| ER | Endoplasmic reticulum |
| FTD | Frontotemporal dementia |
| GPCR | G-coupled protein receptors |
| GSK-3 | Glycogen synthase kinase 3 |
| HSPGs | Heparan sulfate proteoglycans |
| iPSC | Induced pluripotent stem cells |
| MAPT | Microtubule-associated protein Tau |
| MW | Molecular weight |
| NFT | Neurofibrillary tangle |
| OGA | O-GlcNAcase |
| P-Tau | Phosphorylated Tau |
| PDE | Phosphodiesterase |
| PET | Positron emission tomography |
| PHF | Paired helical filament |
| PK | Pharmacokinetics |
| PP2A | Protein phosphatase 2 |
| PROTAC | Proteolysis targeting chimera |
| PSP | Progressive supranuclear palsy |
| PTM | Post-translational modification |
| SG | Stress granule |
| TTBK1 | Tau tubulin kinase 1 |
| UPR | Unfolded protein response |
| UPS | Ubiquitin proteasome system |